Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 2.81
-0.355 %
$ 6.27 M
Market Cap
-0.62
P/E
CASH FLOW STATEMENT
-8.08 M
OPERATING CASH FLOW
-1.18 M
INVESTING CASH FLOW
9.42 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
IM Cannabis Corp.
| Net Income | -10.2 M |
| Depreciation & Amortization | 3 M |
| Capital Expenditures | -581 K |
| Stock-Based Compensation | 225 K |
| Change in Working Capital | 1.4 M |
| Others | -3.75 M |
| Free Cash Flow | -8.66 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Apr-2019 | Apr-2018 | Apr-2017 | Apr-2016 | Apr-2015 | Apr-2014 | Apr-2013 | Apr-2012 | Apr-2011 | Apr-2010 | Apr-2009 | Apr-2008 | Apr-2007 | Apr-2006 | Apr-2005 | Apr-2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||||
| Net Income | (10.2) | (191.3) | (18.5) | (28.7) | (7.4) | (0.1) | (0.1) | 15.8 K | 45.6 K | 37.7 K | (0.2) | (10.0) | (0.5) | (0.7) | (1.3) | (1.4) | (0.8) | (0.6) | (0.8) | 5.21 K | (0.7) |
| Depreciation & Amortization | 3.0 | 7.3 | 5.7 | 0.9 | 0.6 | 0.2 | 81 K | 0 | 514 | 5.61 K | 10.2 K | 19.9 K | 14.6 K | 17 K | 12.6 K | 14.6 K | 10.2 K | 2.29 K | 2.52 K | 3.96 K | 3.96 K |
| Deferred Income Tax | 0.4 | (3.0) | 0.3 | 66 K | 95 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.3) |
| Stock Based Compensation | 0.2 | 3.8 | 7.5 | 3.4 | 2.7 | 0 | 0 | 0 | 0 | 0 | 32 K | 0 | 0 | 66.2 K | 0.8 | 1.0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | (2.9) | 136.1 | (18.5) | 18.0 | 0.9 | (0.2) | 5.01 K | 500 | 1.14 K | (0.2) | 24.9 K | 9.7 | 1 | 0 | 0 | 0 | 0.4 | 32.5 K | 0.5 | (0.4) | 0.6 |
| Change in Working Capital | 1.4 | 34.5 | (10.8) | (1.5) | (2.6) | 71.3 K | 28.8 K | 15.2 K | 17.4 K | 20.5 K | 91.1 K | 63.9 K | 71.1 K | 46.6 K | 1.2 K | (0.8) | 82.9 K | 0.3 | 52.9 K | 75.2 K | 28.9 K |
| Cash From Operations | (8.1) | (12.6) | (34.4) | (7.9) | (6.0) | 46.3 K | 96.1 K | 0 | 26.6 K | (0.2) | 82.9 K | (0.2) | (0.4) | (0.6) | (0.5) | (1.2) | (0.4) | (0.4) | (0.3) | (0.3) | (0.3) |
| INVESTING CASH FLOW | |||||||||||||||||||||
| Capital Expenditures | (0.6) | (1.6) | (4.6) | (2.7) | (1.5) | (0.7) | (0.4) | 0 | 0 | 0 | 0 | (0.3) | (0.4) | 68 K | (0.6) | (2.5) | (1.9) | 78.5 K | 6.36 K | 25.7 K | (0.1) |
| Other Items | (0.6) | 0.2 | (4.4) | (1.4) | (2.2) | 0 | 0 | 0 | 0 | 26.6 K | 0 | 0 | 0 | (1.4) | (0.5) | (0.4) | (0.1) | 92.2 K | (0.3) | (0.3) | (0.2) |
| Cash From Investing Activities | (1.2) | (1.4) | (9.0) | (4.1) | (3.8) | (0.7) | (0.4) | 0 | 0 | 26.6 K | 0 | (0.3) | (0.4) | (1.5) | (1.1) | (2.9) | (2.0) | 13.7 K | (0.3) | (0.3) | (0.3) |
| FINANCING CASH FLOW | |||||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.1 K | (0.3) | 55.9 K | 0 | 0 | 0 | 13.3 K |
| Total Debt Repaid | 69 K | 3.0 | 7.2 | (0.2) | (0.1) | 0 | 0 | 0 | 21 K | 0 | 1 K | (0.2) | 0.2 | 0 | 0 | 14.7 K | 0 | 0 | 0 | 0 | 50 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 7.7 | 1.8 | 13.4 | 6.9 | 1.6 | 79.2 K | 0 | 0 | 0 | 0.2 | 5.57 K | 0.4 | (0.5) | 0.5 | 11 K | 0 | 0 | 1.1 | 0.7 | 0 | 50 K |
| Cash From Financing Activities | 9.4 | 4.8 | 48.7 | 6.7 | 17.1 | 79.2 K | 100 K | 0 | 21 K | 0.2 | 73.4 K | 0.3 | 0.5 | 0.5 | 3.1 | 4.3 | 1.7 | 1.1 | 0.7 | 0.2 | 1.3 |
| CHANGE IN CASH | |||||||||||||||||||||
| Net Change In Cash | (0.6) | (11.5) | 5.0 | (5.0) | 6.3 | 33 K | 3.86 K | 0 | 5.57 K | 5.36 K | 9.46 K | (0.2) | (0.2) | (1.7) | 1.5 | 0.3 | (0.8) | 0.7 | 0.1 | (0.5) | 0.7 |
| FREE CASH FLOW | |||||||||||||||||||||
| Free Cash Flow | (8.7) | (14.2) | (39.0) | (10.6) | (7.5) | (0.8) | (0.5) | 0 | 26.6 K | (0.2) | 82.9 K | (0.5) | (0.8) | (0.7) | (1.1) | (3.7) | (2.3) | (0.5) | (0.3) | (0.3) | (0.4) |